Neumol Pediatr 2022; 17 (2): 46 - 51 Revista Neumología Pediátrica | Contenido disponible en www.neumologia-pediatrica.cl 51 Función pulmonar en fibrosis quística 25. Waters V. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Resir J 2012; 40(1):61-6. DOI:10.1183/09031936.00159111 26. Lukic KZ, CoatesAL. Does the FEF 25-75 or the FEF 75 have any value in assessing lung disease in children with cystic fibrosis or asthma? Pediatr Pulmonol. 2015;50(9):863–8 27. Merel C. J. Oudraad. Assessment of early lung disease in young children with CF: A comparison between pressure-controlled and free-breathing chest computed tomography. Pediatric Pulmonology. 2020; 55:1161–1168 28. Goralski J, Stewart N, Woods J. Novel Imaging Techniques for Cystic Fibrosis Lung Disease. Pediatr Pulmonol. 2021; 56(Suppl 1): S40–S54. doi:10.1002/ppul.24931. 29. Rosenow T, Oudraad MC, Murray CP, Turkovic L, Kuo W, de Bruijne M, Ranganathan SC, et al. Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis. Am J Respir Crit Care Med. 2015 May 15;191(10):1158-65. doi: 10.1164/rccm.201501-0061OC. 30. Kuo W, de Bruijne M, Petersen J, Nasserinejad K, Ozturk H, Chen Y, et al. Diagnosis of bronchiectasis and airway wall thickening in children with cystic fibrosis: Objective airway-artery quantification. Eur Radiol. 2017 11;27(11):4680–4689. 31. Ranganathan SC, Hall GL, Sly PD, Stick S, Douglas T. Australian Respiratory Early Surveillance Team for Cystic Fibrosis: Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It? Am J Respir Crit Care Med. 2017 6 15;195(12):1567– 1575. DOI: 10.1164/rccm.201606-1107 32. Loeve M, Rosenow T, Gorbunova V, Hop W, Tiddens H, De Bruijine M. Reversibility of trapped air on chest computed tomography in cystic fibrosis patients. Eur J Radiol. 2015 6;84(6):1184–90. 33. Ramsey K, Rosenow T, Turkovic L, Skoric B, Banton G, Admas AM, et al. Lung Clearance Index and Structural Lung Disease on Computed Tomography in Early Cystic Fibrosis. Am J Respir Crit Care Med. 2016; Jan 1; 193(1):60-7. DOI: 10.1164/rccm.201507-1409OC 34. Stahl M, Wielputz MO, Graeber SY, Joachim C, Sommerburg O, Kauczor H, et al. Comparison of Lung Clearance Index andMagnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis. Am J Respir Crit CareMed. 2017 2 1;195(3):349–359. 35. Brody AS, Kosorok MR, Li Z, Broderick L, Foster J, Laxova A, et al. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging. 2006 3;21(1):14–21. 36. Benlala I, Hocke F, Macey J, Bui S, Berger P, Laurent F, et al. Quantification of MRI T2-weighted High Signal Volume in Cystic Fibrosis: APilot Study. Radiology. 2020 1;294(1):186– 196. 37. Roach DJ, Cremillieux Y, Fleck RJ, Brody A, Serai S, Szczesniack R, et al. Ultrashort Echo-Time Magnetic Resonance Imaging Is a Sensitive Method for the Evaluation of Early Cystic Fibrosis Lung Disease. Ann Am Thorac Soc. 2016 11;13(11):1923–1931. 38. Stahl M, Wielputz MO, Graeber SY, Joachim C, Sommerburg O, Kauczor H, et al. Comparison of Lung Clearance Index andMagnetic Resonance Imaging for Assessment of Lung Disease in Children with Cystic Fibrosis. Am J Respir Crit CareMed. 2017 2 1;195(3):349–359. 39. McDonald RJ, McDonald JS, Kallmes DF, Jentoft D, Murray D, Thielen K, et al. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015 6;275(3):772–82. 40. Marshall H, Horsley A, Taylor CJ, Smith L, Hughes D, Horn F, et al. Detection of early subclinical lung disease in children with cystic fibrosis by lung ventilation imaging with hyperpolarised gasMRI. Thorax. 2017 8;72(8):760-62. 41. Smith L, Marshall H, Aldag I, Horn F, Collier G, Hughes D, et al. Longitudinal Assessment of ChildrenwithMild Cystic Fibrosis Using Hyperpolarized Gas Lung Magnetic Resonance Imaging and Lung Clearance Index. Am J Respir Crit Care Med. 2018 2 1;197(3):397–400. 42. Altes TA, Johnson M, Fidler M, Botfield M, Tustison N, Salinas C, et al. Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis. J Cyst Fibros. 2017 3;16(2):267–74. 43. Mirjam Stahl, Steinke E, Mall M. Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis. Genes.2021;12(6):803. https://doi.org/10.3390/ genes12060803 44. H.L.Barr, Bihouee T, Zwitserloot A M. A year in review: Real word evidence, functional monitoring and emerging therapeutics in 2021, Journal of Cystic Fibrosis, 2022,21(2):19196. DOI: 10.1016/j.jcf.2022.02.014
RkJQdWJsaXNoZXIy MTYwMjk1